Page last updated: 2024-08-03 11:59:07

cgp 29287

Description

CGP 29287: see also record for renin inhibitory peptide, statine [MeSH]

Cross-References

ID SourceID
PubMed CID25078118
MeSH IDM0132268

Synonyms (11)

Synonym
cgp-29,287
93287-54-8
l-lysine, n6-((1,1-dimethylethoxy)carbonyl)-n2-(n-(n-(3-hydroxy-6-methyl-1-oxo-4-((n-(n-(1-(n2-(n2-((phenylmethoxy)carbonyl)-l-arginyl)-l-arginyl)-l-prolyl)-l-phenylalanyl)-l-histidyl)amino)heptyl)-l-isoleucyl)-l-histidyl)-, methyl ester, (s-(r*,r*))-
cgp 29287
cgp-29287
DLAHCJHYEAZDLE-VRYQDWSQSA-N
z-arg-arg-pro-phe-his-sta-ile-his-nepsilon-boc-lys methyl ester, >=85% (hplc)
DTXSID10239364
mfcd00133577
methyl n2-((3s,4s)-4-((s)-2-((s)-2-((s)-1-(((benzyloxy)carbonyl)-l-arginyl-l-arginyl)pyrrolidine-2-carboxamido)-3-phenylpropanamido)-3-(1h-imidazol-4-yl)propanamido)-3-hydroxy-6-methylheptanoyl)-l-isoleucyl-l-histidyl-n6-(tert-butoxycarbonyl)-l-lysinate
AKOS040744599

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (76.92)18.7374
1990's3 (23.08)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
aldosterone11beta-hydroxy steroid;
18-oxo steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid hormone;
mineralocorticoid;
primary alpha-hydroxy ketone;
steroid aldehyde
human metabolite;
mouse metabolite
1989198935.0low010000
valineL-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid;
valine
algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
1994199430.0low001000
valsartanbiphenylyltetrazole;
monocarboxylic acid amide;
monocarboxylic acid
angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
1994199430.0low001000
3-((2'-carboxybiphenyl-4-yl)methyl)-2-cyclopropyl-7-methyl-3h-imidazo(4,5-b)pyridine1994199430.0low001000
h 1421985198539.0low010000
angiotensin iiamino acid zwitterion;
angiotensin II
human metabolite1988199433.7medium021000
teprotidepeptide1985198539.0low010000
enalaprildicarboxylic acid monoester;
dipeptide
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
geroprotector;
prodrug
1986198936.5medium040000
enalaprilat anhydrousdicarboxylic acid;
dipeptide
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
1986199435.0medium021000
benazeprilatbenzazepine;
dicarboxylic acid;
lactam
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor1987199433.5medium011000
trandolaprildicarboxylic acid monoester;
dipeptide;
ethyl ester;
organic heterobicyclic compound;
secondary amino compound;
tertiary carboxamide
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug
1994199430.0low001000
angiotensinogen1985199435.0medium021000
angiotensin iangiotensin;
peptide zwitterion
human metabolite;
neurotransmitter agent
1987198836.5low020000
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Disease Models, Animal01989198935.0medium010000
Goldblatt Syndrome01987198737.0medium010000
Hypertension, Renal01989198935.0medium010000
Hypertension, Renovascular01987198737.0medium010000
Infarct01987198737.0medium010000

Long-term Use (1)

ArticleYear
Sustained reduction in blood pressure during chronic administration of a renin inhibitor to normotensive marmosets.
Journal of cardiovascular pharmacology, , Volume: 10 Suppl 7
1987